BIR clarifies tax rules for senior citizen medicine discounts

MANILA — The Bureau of Internal Revenue (BIR) has issued updated guidance on tax treatment of senior citizen discounts for pharmaceutical products, clarifying procedures for industry participants seeking to claim related tax deductions. The amendments, codified under Revenue Regulations No. 7-2026, modernize regulations that have governed the practice since the early 2010s. The revision addresses longstanding gaps in how the original rules applied to cost-sharing arrangements among different players in the pharmaceutical supply chain. Under Philippine law, senior citizens are entitled to discounts on essential medicines. The updated regulations establish clearer parameters for how pharmaceutical manufacturers, wholesale distributors, and retail pharmacies can document and claim tax deductions when they collectively absorb the cost of providing these mandated discounts. Industry observers noted the guidance provides much-needed clarity on a practice that had operated under interpretive ambiguity for years. The BIR's move is expected to facilitate compliance while ensuring that the tax incentive structure supports the government's objective of making medicines more affordable for elderly Filipinos. Stakeholders in the pharmaceutical sector have indicated the updated rules will help standardize accounting practices across the industry.